Sormani MP, Häring DA, Kropshofe H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, #277.
Prix Galien voor Spinraza, FreeStyle Libre en Reinoud Gosens
nov 2018 | Multipele Sclerose, Neuro-musculair